Gerresheimer stock faces Q1 results after cash flow improves
Published on 09/29/2026 at 10:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gerresheimer (ISIN DE000A0LD6E6) was trading at EUR 27.44 on Xetra on September 29, 2026, down 0.15 percent from the prior close of EUR 27.48. The company is scheduled to publish its Q1 2026 results on September 30, 2026, at 3:00 p.m. CEST, according to Gerresheimer.
Results arrive after cash discipline
The upcoming release follows a quarter in which cash management took priority over short-term earnings. In Q1 2026, free cash flow before M&A improved from negative EUR 142 million in Q1 2025 to negative EUR 32 million, while revenue increased by EUR 5 million, according to Yahoo Finance.
The cash improvement came with pressure on operating profitability. Adjusted EBITDA fell by EUR 15 million year over year, while net capital expenditure declined from EUR 113 million to EUR 56 million in the quarter. That trade-off gives the September 30 report two distinct tests: whether cash conversion holds and whether the earnings burden from lower capacity utilization begins to ease.
Medical systems offset glass weakness
The portfolio picture was uneven in Q1 2026. Containment and Delivery Systems revenue rose to EUR 296 million from EUR 281 million, an 8.8 percent organic increase, and adjusted EBITDA advanced to EUR 61 million from EUR 51 million, Yahoo Finance reported from the earnings call. By contrast, Moulded Glass revenue dropped to EUR 144 million from EUR 160 million, and adjusted EBITDA declined to EUR 6 million from EUR 32 million.
Management has linked the recovery case to portfolio changes and operational savings. The earnings-call transcript describes a targeted EBITDA improvement of EUR 50 million to EUR 70 million through the GTO transformation, with the full run-rate benefit targeted for 2028. Gerresheimer also expects the sale of Centor and Primary Packaging Plastics to support deleveraging, with the combined transaction valued at EUR 1.5 billion.
Analyst target remains below quote
wallstreetONLINE reported on September 1, 2026, that Deutsche Bank Research maintained a Hold rating and a EUR 26.00 price target. The target lies 5.25 percent below the Xetra price of EUR 27.44, making the scheduled results a direct test of whether the cash-flow progress can outweigh the weaker glass operations.
Xetra quote sits 28.40 percent below high
Gerresheimer stock was trading at EUR 27.44 on Xetra at 10:00 a.m. CEST on September 29, 2026. The session range was EUR 27.14 to EUR 27.68, the 52-week range was EUR 14.83 to EUR 38.32, and market capitalization was EUR 947.8 million.
Gerresheimer stock data
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Trading venue: Xetra
- Price (as of September 29, 2026, 10:00 a.m. CEST): EUR 27.44
- Market capitalization: EUR 947.8 million (as of September 29, 2026)
- 52-week range: EUR 14.83-EUR 38.32 (as of September 29, 2026)
- Sector / Industry: Healthcare Equipment and Supplies
